BIN1 Is Decreased in Sporadic but Not Familial Alzheimer's Disease or in Aging

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Glennon, Elizabeth B C ^a,c   Whitehouse, Isobel J ^a   Miners, J Scott ^b   Kehoe, Patrick G ^b   Love, Seth ^b   Kellett, Katherine A B ^a   Hooper, Nigel M ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; BRAIN PROTEIN; BRIDGING INTEGRATOR 1 PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEURON SPECIFIC ENOLASE; SMALL INTERFERING RNA; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; AMYLOID PLAQUE; ARTICLE; CANCER CELL CULTURE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; FAMILIAL DISEASE; FEMALE; FRONTAL CORTEX; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NERVE DEGENERATION; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84886914118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078806     Document Type: Article

References (43)

1. Bertram L, Tanzi RE, (2010) Alzheimer disease: New light on an old CLU. Nat. Rev Neurol 6: 11-13. doi:10.1038/nrneurol.2009.213.
2. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2011) Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J Alzheimers Dis 24: 751-758. PubMed: 21321396.
3. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, et al. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093. doi:10.1038/ng.440. PubMed: 19734902.
4. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435. doi:10.1038/ng.803. PubMed: 21460840.
5. Hu X, Pickering E, Liu YC, Hall S, Fournier H, et al. (2011) Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease. PLOS ONE 6: e16616. doi:10.1371/journal.pone.0016616. PubMed: 21390209.
6. Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, et al. (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303: 1832-1840. doi:10.1001/jama.2010.574. PubMed: 20460622.
7. Wijsman EM, Pankratz ND, Choi Y, Rothstein JH, Faber KM, et al. (2011) Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLOS Genet 7: e1001308. PubMed: 21379329.
8. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099. doi:10.1038/ng.439. PubMed: 19734903.
9. Negorev D, Riethman H, Wechsler-Reya R, Sakamuro D, Prendergast GC, et al. (1996) The Bin1 Gene Localizes to Human Chromosome 2q14 by PCR Analysis of Somatic Cell Hybrids and Fluorescence in Situ Hybridization. Genomics 33: 329-331. doi:10.1006/geno.1996.0205. PubMed: 87254068660989.
10. Tsutsui K, Maeda Y, Seki S, Tokunaga A, (1997) cDNA cloning of a novel amphiphysin isoform and tissue-specific expression of its multiple splice variants. Biochem Biophys Res Commun 236: 178-183. doi:10.1006/bbrc.1997.6927. PubMed: 9223448.
11. Lee JH, Cheng R, Barral S, Reitz C, Medrano M, et al. (2011) Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals. Arch Neurol 68: 320-328. doi:10.1001/archneurol.2010.292. PubMed: 21059989.
12. Chapuis J, Hansmannel F, Gistelinck M, Mounier A, Van Cauwenberghe C, et al. (2013) Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology. Mol Psychiatry Epub ahead of print. doi:10.1038/mp.2013.1. PubMed: 23399914.
13. Butler MH, David C, Ochoa GC, Freyberg Z, Daniell L, et al. (1997) Amphiphysin. p. pp. II (SH3P9; BIN1), a member of the amphiphysin/Rvs family, is concentrated in the cortical cytomatrix of axon initial segments and nodes of ranvier in brain and around T tubules in skeletal muscle. J Cell Biol 137: 1355-1367.
14. Di Paolo G, Sankaranarayanan S, Wenk MR, Daniell L, Perucco E, et al. (2002) Decreased synaptic vesicle recycling efficiency and cognitive deficits in amphiphysin 1 knockout mice. Neuron 33: 789-804. doi:10.1016/S0896-6273(02)00601-3. PubMed: 11879655.
15. Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS, (1997) Identification and characterization of a nerve terminal-enriched amphiphysin isoform. J Biol Chem 272: 16700-16706. doi:10.1074/jbc.272.26.16700. PubMed: 9195986.
16. Wigge P, Köhler K, Vallis Y, Doyle CA, Owen D, et al. (1997) Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Cell Biol 8: 2003-2015. doi:10.1091/mbc.8.10.2003. PubMed: 9348539.
17. Leprince C, Romero F, Cussac D, Vayssiere B, Berger R, et al. (1997) A new member of the amphiphysin family connecting endocytosis and signal transduction pathways. J Biol Chem 272: 15101-15105. doi:10.1074/jbc.272.24.15101. PubMed: 9182529.
18. Wigge P, McMahon HT, (1998) The amphiphysin family of proteins and their role in endocytosis at the synapse. Trends Neurosci 21: 339-344. doi:10.1016/S0166-2236(98)01264-8. PubMed: 9720601.
19. Whitehouse IJ, Jackson C, Turner AJ, Hooper NM, (2010) Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease. J Alzheimers Dis 22: 1023-1031. PubMed: 20930299.
20. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, et al. (2008) Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron 58: 42-51. doi:10.1016/j.neuron.2008.02.003. PubMed: 18400162.
21. Ehehalt R, Keller P, Haass C, Thiele C, Simons K, (2003) Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 160: 113-123. doi:10.1083/jcb.200207113. PubMed: 12515826.
22. Koo EH, Squazzo SL, (1994) Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J Biol Chem 269: 17386-17389. PubMed: 8021238.
23. Schneider A, Rajendran L, Honsho M, Gralle M, Donnert G, et al. (2008) Flotillin-dependent clustering of the amyloid precursor protein regulates its endocytosis and amyloidogenic processing in neurons. J Neurosci 28: 2874-2882. doi:10.1523/JNEUROSCI.5345-07.2008. PubMed: 18337418.
24. Wu L, Candille SI, Choi Y, Xie D, Jiang L, et al. (2013) Variation and genetic control of protein abundance in humans. Nature 499: 79-82. doi:10.1038/nature12223. PubMed: 23676674.
25. Li M, Wang IX, Li Y, Bruzel A, Richards AL, et al. (2011) Widespread RNA and DNA sequence differences in the human transcriptome. Science 333: 53-58. doi:10.1126/science.1207018. PubMed: 21596952.
26. Lundberg E, Fagerberg L, Klevebring D, Matic I, Geiger T, et al. (2010) Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 6: 450. PubMed: 21179022.
27. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259. doi:10.1007/BF00308809. PubMed: 1759558.
28. Braak H, Braak E, Bohl J, (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33: 403-408. doi:10.1159/000116984. PubMed: 8307060.
29. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, et al. (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 8: 1-13. doi:10.1016/S1552-5260(12)00093-3. PubMed: 22265587.
30. Morrissette DA, Parachikova A, Green KN, LaFerla FM, (2009) Relevance of transgenic mouse models to human Alzheimer disease. J Biol Chem 284: 6033-6037. PubMed: 18948253.
31. Jorm AF, Korten AE, Henderson AS, (1987) The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 76: 465-479. doi:10.1111/j.1600-0447.1987.tb02906.x. PubMed: 3324647.
32. Song MS, Baker GB, Todd KG, Kar S, (2011) Inhibition of beta-amyloid1-42 internalization attenuates neuronal death by stabilizing the endosomal-lysosomal system in rat cortical cultured neurons. Neuroscience 178: 181-188. doi:10.1016/j.neuroscience.2010.12.055. PubMed: 21262324.
33. Mackic JB, Stins M, McComb JG, Calero M, Ghiso J, et al. (1998) Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1- 40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest 102: 734-743. doi:10.1172/JCI2029. PubMed: 9710442.
34. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, et al. (1989) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39: 1159-1165. doi:10.1212/WNL.39.9.1159. PubMed: 2771064.
35. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease. Brain Pathol 20: 787-793. doi:10.1111/j.1750-3639.2010.00374.x. PubMed: 20175777.
36. van Helmond Z, Miners JS, Kehoe PG, Love S, (2010) Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathol 20: 468-480. doi:10.1111/j.1750-3639.2009.00321.x. PubMed: 19725829.
37. Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, et al. (2007) Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology 68: 1726-1729. doi:10.1212/01.wnl.0000261920.03297.64. PubMed: 17502555.
38. Chalmers K, Wilcock GK, Love S, (2003) APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathol Appl Neurobiol 29: 231-238. doi:10.1046/j.1365-2990.2003.00457.x. PubMed: 12787320.
39. Miners JS, Baig S, Tayler H, Kehoe PG, Love S, (2009) Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol 68: 902-914. doi:10.1097/NEN.0b013e3181afe475. PubMed: 19606063.
40. Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, et al. (2009) Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. J Neurol 256: 717-720. doi:10.1007/s00415-009-5000-2. PubMed: 19240967.
41. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, et al. (2010) The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway. J Biol Chem 285: 41443-41454. doi:10.1074/jbc.M110.141390. PubMed: 20961856.
42. Haugabook SJ, Yager DM, Eckman EA, Golde TE, Younkin SG, et al. (2001) High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid beta peptide (Abeta). J Neurosci Methods 108: 171-179. doi:10.1016/S0165-0270(01)00388-0. PubMed: 11478976.
43. Rushworth JV, Griffiths HH, Watt NT, Hooper NM, (2013) Prion protein-mediated toxicity of amyloid-beta oligomers requires lipid rafts and the transmembrane LRP1. J Biol Chem 288: 8935-8951. doi:10.1074/jbc.M112.400358. PubMed: 23386614.